BSE filing, NSE: FERMENTA. Summary written from the filing by ALFA Finder's alert engine.
Fermenta Biotech Ltd: key numbers
- Share price
- ₹420.00
- Market cap
- ₹1,236 Cr
- Revenue (annual)
- ₹525.4 Cr
- Net profit (annual)
- ₹71.77 Cr
- P/E (TTM)
- 20.4×Sector 47.2×
- Promoter holding
- 60.12%-3.97% QoQ
- FII holding
- 1.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fermenta Biotech Ltd
All →Fermenta Biotech Board Meeting Date
Fermenta Biotech schedules a board meeting on November 5, 2026 to approve unaudited quarterly and half-year results. The trading window stays closed until 48 hours after results.
Fermenta Biotech Other Announcement
Fermenta Biotech Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Fermenta Biotech Promoter Selling
Fermenta Biotech Limited promoter Preeti Thakkar sold 11,65,938 equity shares (3.96%) in the open market. Her shareholding decreased from 7.61% to 3.65% following the transaction.
Fermenta Biotech Promoter Selling: ₹55.34 Cr
Fermenta Biotech Ltd promoter Preeti Thakkar sold 11,65,938 equity shares via open market sale. The transaction valued at ₹55.34 Crore reduced her stake from 7.61% to 3.65%.
- Value
- ₹55.34 Cr
Fermenta Biotech Other Announcement
KMP Sumesh Gandhi sold a total of 3,900 equity shares in three separate market transactions on September 7, 8, and 9, 2026.
- Value
- ₹0.20 Cr
Fermenta Biotech Partnership
Fermenta Biotech Limited signed an exclusive licence agreement with VIT Vellore to commercialize Vitamin B12 fortification technology for fermented foods, enhancing its product portfolio.
- From
- Vellore Institute of Technology (VIT), Vellore
Other price movement clarification announcements
All →Au Small Finance Bank Price Movement Clarification
AU Bank clarified a potential data leak at a third-party platform, possibly affecting about 28.5 lakh vehicle loan customers. It says operations and finances are unaffected.
Sun Pharmaceutical Industries Price Movement Clarification
Sun Pharma said a 30 October 2026 news report concerned August 2026 developments, not new events. It confirmed no undisclosed material information explains the share price movement.
Tata Communications Price Movement Clarification
Tata Communications responded to a news report on STT GDC India's sale, stating no material event requires Regulation 30 disclosure. It will disclose as required.
Milton Industries Price Movement Clarification
Milton Industries responded to NSE's 29 October 2026 query on significant share price movement. The company said no undisclosed price-sensitive information exists and the move is market-driven.
Mazagon Dock Shipbuilders Price Movement Clarification
Mazagon Dock clarified a news report on proposed shipbuilding hubs amid a share price move. The company is exploring partnerships and financing, with no value disclosed.
Dhvija Finance Price Movement Clarification
Dhvija Finance Ltd stated the price movement is market-driven with no undisclosed events, confirming full regulatory compliance. No impending announcements exist beyond upcoming Q3 results.